Navigation Links
Morris Animal Foundation Receives $1 Million Donation From Hill's for Cat Health Research - Cat Lovers Have Reason to Celebrate
Date:8/12/2008

Donation Also Includes Genetic Research Data to Identify New Tools for

Veterinarians, Enhancing Cat Health

DENVER, Aug. 12 /PRNewswire/ -- Morris Animal Foundation (MAF) has received a donation of $1 million from Hill's Pet Nutrition, accompanied by a donation of ground-breaking genetic research data developed by Hill's researchers. These donations will assist MAF in the continuation of its 60-year history of funding research to help cats live happier, healthier lives. Since its founding, MAF has been at the forefront of efforts to advance cat health, and in November 2008, MAF will launch a global research effort on behalf of cats.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040701/LAMAFLOGO)

Dr. Patricia Olson, MAF president and CEO, comments on cats being slighted in health research funding and veterinary care. "It is a sad irony that cats are the most popular pet in our country, yet far too little research funding and veterinary care is being provided to meet cats' unique health needs," Dr. Olson says. "Thanks to Hill's extraordinary donation to MAF, cats will be given a dramatically better opportunity for a long, healthy life."

Research emanating from these genetic tools should provide veterinarians with increased knowledge and capabilities to prevent and treat a wide range of cat diseases. Cat lovers everywhere can celebrate this milestone in feline health. It is hoped this increased focus on feline health and public awareness of the effort, will motivate cat owners to take their pets to the veterinarian more often. Presently, as documented by industry information, a large number of cats living in the United States do not receive regular health checkups and preventive veterinary care.

Part of this donation will establish an international coalition for feline genomic research. This coalition will advise MAF on the pot
'/>"/>

SOURCE Morris Animal Foundation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. First Circuit Court of Appeals Rules Against Philip Morris in Lights Class Action
2. ABC TV San Francisco Features Canine Cancer Research Story: Saving Our Dogs, Helping Humans Beat Cancer - Work at Morris Animal Foundation, UC-Davis
3. Morris Animal Foundation 2008 Sponsorship Guide Available, Details Current Animal Health Studies
4. Morris Animal Foundation Featured on NASCAR Racecar to Raise Awareness of Pet Cancer
5. Morrison Takes Aim at Underage Drinking in New Radio Campaign
6. PetScreen Supports Morris Animal Foundation Canine Cancer Campaign; Co-Sponsors Two Canine Cancer Studies
7. Perfect Holiday Gift Idea for the Pet-Animal Lover - Pet Health Manual Available With Donation to Morris Animal Foundation
8. Philip Morris International Spin-off Should Spur Nations to Take Urgent Action to Reduce Tobacco Use
9. The Blue Buffalo Foundation for Cancer Research Sponsors Six Morris Animal Foundation Cancer Studies
10. Chicago Tribune Does Story on Canine Cancer, Morris Animal Foundation (MAF) Effort to Find a Cure - MAF Can Provide Information - Local Angles for a Feature Story
11. Pain Management For Pets, Key Strategies For Veterinarians - Live Webcast to Veterinarians, March 13, 7:00 p.m. to 8:00 p.m. (EDT) Via Morris Animal Foundation

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... formation could boost self-esteem, researchers sa... Autistic children are more likely to have handwri...than those without autism, researchers say. , T...alf of the study participants had autism spectrum ...e normal range for perceptual reasoning on an IQ t...
(Date:11/9/2009)...v. 9 /PRNewswire-FirstCall/ - Hard To Treat Diseas...y that Novartis, a US$41 billion international hea..., H1N1 Vaccine partner, Zhejiang Tianyuan Bio-Phar... of Switzerland will begin a five-year, $1 billion...dramatically increase its investment in its China ...
(Date:11/9/2009)... New study highlights positive influence of sports... Rosemont, IL (Vocus) November 9, 2009 -- As...reases. Recent research has highlighted the import...revent these issues. However, a new study publishe...: A Multidisciplinary Approach reveals that there...
(Date:11/9/2009)...mes 2010 National Ambassador ,, WHITE PLAINS,...ffman of Weston, Fla., was born so early and with ...ot say whether he would survive -- or if he would ...d was named March of Dimes 2010 National Ambassado..."My first minutes of motherhood and I was complete...
(Date:11/9/2009)...people went from incapacitated to working again, ... Electrical stimulation of a certain area of the b...epression, say German researchers. , They impla...he brains of 10 people. This area of the brain is...e remember good experiences and puts them in a sta...
Breaking Medicine News(10 mins):Health News:Handwriting Skills May Lag in Kids With Autism 2Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 2Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 3Health News:Novartis to Acquire Majority Stake in Hard to Treat Diseases' (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million 4Health News:High Impact Sports Participation May Improve Bone Mineral Density in Mature Athletes 2Health News:Six-Year-Old Survivor Fights for Preemies Like Himself 2Health News:Six-Year-Old Survivor Fights for Preemies Like Himself 3Health News:Brain Stimulation May Ease Treatment-Resistant Depression 2
...SSEN, Netherlands, May 7 Health ingredients Europ...food & beverage trade show, has been shortlist...est Trade Show Over 2000m2 Award, announced UBM In...ought together 7328 attendees with 450 exhibitors....
...e leader of dementia research in CSIRO,s Preventat...a Szoeke, says the report highlights the challenge...rs predicted to double to 465,000 by 2030. , "Abo...is crisis more effectively." , "By the time suffe...
...g Adults with AD/HD Make a Visit to the Halls of C...rce and Funding for the Mental Health Disorder , ...ll mark the fourth annual national Children,s Ment...ty Disorder (CHADD) and the American Academy of Ch...
...erence Call to Follow Release , , DENVER, May 7 ...the "Company") (OTC Bulletin Board: GLOB), an inte...y, will report its first quarter financial results... http://www.newscom.com/cgi-bin/prnh/20040226/GLO...
...ADELPHIA, May 7 Major League Baseball (MLB) has s...mask legal but banned substances for multi-million...estruction of the game as we know it. Sports team ...fine how the game should be run. , , "MLB is set ...
...ESTER, N.Y., May 7 Recent scientific studies publ...cinogenesis, Oncology, British Journal of Urology,... food extracts Quercetin, EGCG, Glycyrrhizin, and ...nding formulation. Gene-Eden was introduced in Feb...
Other Medicine News:Health News:Health ingredients Europe Shortlisted for AEO's Best Trade Show Over 2000m2 Award 2Health News:Dementia: Early detection is key 2Health News:The New Face of AD/HD Comes to Capitol Hill 2Health News:Global Med Technologies(R), Inc. to Report First Quarter Financial Results on Friday, May 15, 2009 2Health News:Global Med Technologies(R), Inc. to Report First Quarter Financial Results on Friday, May 15, 2009 3Health News:Is Bailout of Major League Baseball Next? Book Explains How Baseball Like Big Businesses Will Fail 2Health News:The Center for the Biology of Chronic Disease Highlights Anti-Cancer Activities of the Food Extracts Quercetin, EGCG, Glycyrrhizin, and Trans-Cinnamaldehyde 2
(Date:11/9/2009)...wire-FirstCall/ -- Arena Pharmaceuticals, Inc. (Na... the third quarter ended September 30, 2009. ,,...on stockholders in the third quarter of 2009 of $3... loss allocable to common stockholders in the thir...hare, and a net loss allocable to common stockhold...
(Date:11/9/2009)...re/ -- Groundbreaking articles in current issues o...time explore, in depth, the emergence of cannabino...ers and its potential benefits for patients. ,,...gton authors, Sunil Aggarwal, PhD who is a member ...ram and who conducted the article,s research and G...
(Date:11/9/2009)...re/ -- Celling Technologies, a subsidiary of Spine...is, Inc. to research potential applications for ad... acquired the global rights in spine for Tissue Ge...nology in November of 2007. Replacing the prior a...lling Technologies to further research adipose tis...
Breaking Medicine Technology:Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 2Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 3Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 4Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 5Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 6Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 7Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 8Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 9Medicinal Use of Marijuana: Past, Present and Future...A Fresh Look by Experts in the Field 2Celling Technologies Signs Exclusive Agreement to Research and Develop Adipose Tissue Stem Cell Technology in Regenerative Medicine Institutes 2Celling Technologies Signs Exclusive Agreement to Research and Develop Adipose Tissue Stem Cell Technology in Regenerative Medicine Institutes 3HHS Awards MedImmune Contract to Manufacture Live Attenuated Nasal Spray Vaccine for Novel Influenza A 28H1N1 29 12381 1HHS Awards MedImmune Contract to Manufacture Live Attenuated Nasal Spray Vaccine for Novel Influenza A 28H1N1 29 12381 2HHS Awards MedImmune Contract to Manufacture Live Attenuated Nasal Spray Vaccine for Novel Influenza A 28H1N1 29 12381 3HHS Awards MedImmune Contract to Manufacture Live Attenuated Nasal Spray Vaccine for Novel Influenza A 28H1N1 29 12381 4Proteolix Presents Positive Clinical Data for Carfilzomib in Multiple Myeloma at the 2009 ASCO Annual Meeting 4502 1Proteolix Presents Positive Clinical Data for Carfilzomib in Multiple Myeloma at the 2009 ASCO Annual Meeting 4502 2Proteolix Presents Positive Clinical Data for Carfilzomib in Multiple Myeloma at the 2009 ASCO Annual Meeting 4502 3Proteolix Presents Positive Clinical Data for Carfilzomib in Multiple Myeloma at the 2009 ASCO Annual Meeting 4502 4Proteolix Presents Positive Clinical Data for Carfilzomib in Multiple Myeloma at the 2009 ASCO Annual Meeting 4502 5Proteolix Presents Positive Clinical Data for Carfilzomib in Multiple Myeloma at the 2009 ASCO Annual Meeting 4502 6Keryx Biopharmaceuticals Announces Positive Data from a Randomized Multi Center Placebo Controlled Phase 2 Combination Study of KRX 0401 28Perifos 4500 1Keryx Biopharmaceuticals Announces Positive Data from a Randomized Multi Center Placebo Controlled Phase 2 Combination Study of KRX 0401 28Perifos 4500 2Keryx Biopharmaceuticals Announces Positive Data from a Randomized Multi Center Placebo Controlled Phase 2 Combination Study of KRX 0401 28Perifos 4500 3Keryx Biopharmaceuticals Announces Positive Data from a Randomized Multi Center Placebo Controlled Phase 2 Combination Study of KRX 0401 28Perifos 4500 4Keryx Biopharmaceuticals Announces Positive Data from a Randomized Multi Center Placebo Controlled Phase 2 Combination Study of KRX 0401 28Perifos 4500 5Keryx Biopharmaceuticals Announces Positive Data from a Randomized Multi Center Placebo Controlled Phase 2 Combination Study of KRX 0401 28Perifos 4500 6
...sdaq: TELK ) reported positive preclinical data f...ecule inhibitors of validated cancer targets,inclu...ented today at the,AACR-NCI-EORTC Conference on Mo...ncisco. Aurora kinases are enzymes that play a ke...-expressed in many human cancers, including breast...
...., a,privately held biopharmaceutical company deve...cular biomarker data demonstrating the overexpress...in in multiple cancers,including ovarian, breast a...ation of PARP overexpression in specific types of ...inical development of the company,s,pipeline of PA...
Other Medicine Technology:Telik Announces Preclinical Data Demonstrating Anti-Cancer Activity of Dual Inhibitors of Aurora Kinase and VEGFR2 2BiPar Genomic Biomarker Data Demonstrate Overexpression of PARP-1 Gene in Multiple Cancer Types 2
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
...ence laboratory and a worldwide leader in innovati...s an extensive test menu of highly complex and uni...gy. Owned by the University of Utah, ARUP Laborato...'s university teaching hospitals and children's ho...
Medicine Products: